Selective inhibitory effects of Smad6 on bone morphogenetic protein type I receptors
Goto K, Kamiya Y, Imamura T, Miyazono K, Miyazawa K.
J Biol Chem. 2007 Jul 13;282(28):20603-11. Epub 2007 May 10.
PMID:17493940 DOI:10.1074/jbc.M702100200
Modulation of the functional binding sites for TGF-beta on the type II receptor leads to suppression of TGF-beta signaling
Shimanuki T, Hara T, Furuya T, Imamura T, Miyazono K.
Oncogene. 2007 May 17;26(23):3311-20. Epub 2006 Dec 4.
PMID:17146441 DOI:10.1038/sj.onc.1210123
Ki26894, a novel transforming growth factor-beta type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line
Ehata S, Hanyu A, Fujime M, Katsuno Y, Fukunaga E, Goto K, Ishikawa Y, Nomura K, Yokoo H, Shimizu T, Ogata E, Miyazono K, Shimizu K, Imamura T.
Cancer Sci. 2007 Jan;98(1):127-33. doi: 10.1111/j.1349-7006.2006.00357.x.
PMID:17129361 DOI:10.1111/j.1349-7006.2006.00357.x
Nuclear and cytoplasmic c-Ski differently modulate cellular functions
Nagata M, Goto K, Ehata S, Kobayashi N, Saitoh M, Miyoshi H, Imamura T, Miyazawa K, Miyazono K.
Genes Cells. 2006 Nov;11(11):1267-80.First published: 12 October 2006
PMID:17054724 DOI:10.1111/j.1365-2443.2006.01018.x
CCAAT/enhancer-binding protein homologous protein (CHOP) regulates osteoblast differentiation
Shirakawa K, Maeda S, Gotoh T, Hayashi M, Shinomiya K, Ehata S, Nishimura R, Mori M, Onozaki K, Hayashi H, Uematsu S, Akira S, Ogata E, Miyazono K, Imamura T.
Mol Cell Biol. 2006 Aug;26(16):6105-16.
PMID:16880521 PMCID:PMC1592788 DOI:10.1128/MCB.02429-05
Smad transcriptional co-activators and co-repressors
Miyazono K, Maeda S, Imamura T.
Smad Signal Transduction, 2006, Volume 5, 277-293, Springer, Review
Part of the Proteins and Cell Regulation book series (PROR, volume 5)
DOI :https://doi.org/10.1007/1-4020-4709-6_14
Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells
Azuma H, Ehata S, Miyazaki H, Watabe T, Maruyama O, Imamura T, Sakamoto T, Kiyama S, Kiyama Y, Ubai T, Inamoto T, Takahara S, Itoh Y, Otsuki Y, Katsuoka Y, Miyazono K, Horie S.
J Natl Cancer Inst. 2005 Dec 7;97(23):1734-46.
PMID:16333029 DOI:10.1093/jnci/dji399
The ALK-5 inhibitor A-83-01 inhibits Smad signaling and epithelial-to-mesenchymal transition by transforming growth factor-beta
Tojo M, Hamashima Y, Hanyu A, Kajimoto T, Saitoh M, Miyazono K, Node M, Imamura T.
Cancer Sci. 2005 Nov;96(11):791-800. First published: 14 October 2005
PMID:16271073 DOI:10.1111/j.1349-7006.2005.00103.x
BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk
Miyazono K, Maeda S, Imamura T.
Cytokine Growth Factor Rev. 2005 Jun;16(3):251-63. Available online 24 May 2005. Review
PMID:15871923 DOI:10.1016/j.cytogfr.2005.01.009
Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases
Morén A, Imamura T, Miyazono K, Heldin CH, Moustakas A.
J Biol Chem. 2005 Jun 10;280(23):22115-23. Epub 2005 Apr 6.
PMID:15817471 DOI:10.1074/jbc.M414027200